• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GRAFTON DBM; BONE GRAFTING MATERIAL, HUMAN SOURCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GRAFTON DBM; BONE GRAFTING MATERIAL, HUMAN SOURCE Back to Search Results
Model Number T42275JPN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Fluid Discharge (2686)
Event Date 03/19/2021
Event Type  Injury  
Manufacturer Narrative
Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Although it is unknown if the device contributed to the reported event, we are filing this mdr for notification purposes.Manufacturing assessment : the non-conformance database (qn and roar) were reviewed and there were no reported events for the subject batch.Four manufacturing records were reviewed: 1.Rttis-015 router for medcleaning donors that will not yield soft tissue 2.Rttis-019 cartridge mill production of fiber for grafton 3.Rtdbm-019-17 grafton matrix strips reaction router 4.Rtdbm-041-08 matrix strips core packaging router no deviations were observed.Grafton matrix strips test reports were reviewed (base sterility, final product sterility, endotoxin, moisture analysis, glycerol content, calcium assay, environmental monitoring).All tests passed.Hcps reviews based on donor charts: the initial response is that the patient had a post-op infection, however, the additional information revealing that it was determined to be an immune response, not an infection.If it was an immune response, it certainly could be a response to the trauma of the surgery and the immune cells would migrate to the surgical wound.Either way, infection or immune reaction, after reviewing the donor chart and the recovery information, i don¿t believe that our product was responsible for the adverse reaction.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from multiple sources (manufacturer representative, healthcare provider, foreign) regarding a patient with drop head syndrome, anterior and posterior surgery was performed in two stages at c3-6 anterior fixation was performed on (b)(6) (friday) and c2-t1 posterior fixation was performed on (b)(6) (friday).It was reported that after the drain was removed after the operation, the wound swelled, yellow exudate leaked from the inside, and the wound opened.It was said that the yellow exudate had been leaking from the postoperative period to the present.Since this event occurred after discharge, re-hospitalization was required 3 days after discharge.The relationship between the reported event and the use of medtronic product was unknown.There was health damage on the patient.There was no infection and there was an immune response, but the value was not a questionable value from the standard value.The result of the culture was the detection of only resident skin bacteria.The patient took loxonin as a pain reliever after surgery and mucosta to protect the gastric mucosa.For atopic dermatitis, take melex, zolpidem, maprotiline, and pranlukast.Voalla, gentamicin, vitra, tacrolimus, propeto, fenazol, and geben were used as external medicines in ointments.Re-hospitalization and extension of hospitalization period had occurred.(b)(6) 2021 after admission and discharge due to surgery, the patient was readmitted due to this event from (b)(6) 2021 to the present.Patient medical history- atopic dermatitis, shingles, thyroid cyst (thyroid function is normal) date of original discharge: (b)(6) 2021.Exudate from the implanted site.No treatment performed.Readmitted for exudate from (b)(6) 2021 onwards.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRAFTON DBM
Type of Device
BONE GRAFTING MATERIAL, HUMAN SOURCE
MDR Report Key11594014
MDR Text Key260550581
Report Number2246640-2021-00002
Device Sequence Number1
Product Code NUN
Combination Product (y/n)N
PMA/PMN Number
K051188
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial
Report Date 03/31/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/31/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/10/2023
Device Model NumberT42275JPN
Device Catalogue NumberT42275JPN
Was Device Available for Evaluation? No
Date Manufacturer Received03/19/2021
Date Device Manufactured11/10/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age46 YR
Patient Weight52
-
-